Pre-Exposure Prophylaxis for HIV Infection as a Public Health Tool

被引：9

作者：

Beyrer, Chris ^{[1
]}

McCormack, Sheena ^{[2
]}

Grulich, Andrew ^{[3
]}

机构：

[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA

[2] UCL, MRC Clin Trials Unit, London, England

[3] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia

来源：

JOURNAL OF LAW MEDICINE & ETHICS | 2022年 / 50卷

基金：

英国医学研究理事会;

关键词：

HIV; Pre-Exposure Prophylaxis; Incidence; Public Health Tool; ANTIRETROVIRAL PROPHYLAXIS; MEN; PREVENTION; SEX; GAY;

D O I：

10.1017/jme.2022.31

中图分类号：

B82 [伦理学（道德学）];

学科分类号：

摘要：

The efficacy of pre-exposure prophylaxis, PrEP, with antiviral agents for prevention of HIV infection has been demonstrated in multiple randomized controlled trials and demonstration projects. These trials have studied prevention at the individual level. The effectiveness of PrEP as a public health intervention to reduce HIV incidence at community and population levels is being actively evaluated but is less well described. In reviewing the available data on PrEP as a public health intervention, three significant examples have demonstrated success, and all have been among communities of gay, bisexual and other men who have sex with men (MSM).

引用

页码：24 / 28

页数：5

共 25 条

[1]

[Anonymous], 2019 MONITORING SELE

[2]

[Anonymous], 2015, C RETR OPP INF ATL M

[3] Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women [J].

Baeten, J. M. ;

Donnell, D. ;

Ndase, P. ;

Mugo, N. R. ;

Campbell, J. D. ;

Wangisi, J. ;

Tappero, J. W. ;

Bukusi, E. A. ;

Cohen, C. R. ;

Katabira, E. ;

Ronald, A. ;

Tumwesigye, E. ;

Were, E. ;

Fife, K. H. ;

Kiarie, J. ;

Farquhar, C. ;

John-Stewart, G. ;

Kakia, A. ;

Odoyo, J. ;

Mucunguzi, A. ;

Nakku-Joloba, E. ;

Twesigye, R. ;

Ngure, K. ;

Apaka, C. ;

Tamooh, H. ;

Gabona, F. ;

Mujugira, A. ;

Panteleeff, D. ;

Thomas, K. K. ;

Kidoguchi, L. ;

Krows, M. ;

Revall, J. ;

Morrison, S. ;

Haugen, H. ;

Emmanuel-Ogier, M. ;

Ondrejcek, L. ;

Coombs, R. W. ;

Frenkel, L. ;

Hendrix, C. ;

Bumpus, N. N. ;

Bangsberg, D. ;

Haberer, J. E. ;

Stevens, W. S. ;

Lingappa, J. R. ;

Celum, C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (05) :399-410

[4] The disconnect between individual-level and population-level Goatee. HIV prevention benefits of antiretroviral treatment [J].

Baral, Stefan ;

Rao, Amrita ;

Sullivan, Patrick ;

Phaswana-Mafuya, Nancy ;

Diouf, Daouda ;

Millett, Greg ;

Musyoki, Helgar ;

Geng, Elvin ;

Mishra, Sharmistha .

LANCET HIV, 2019, 6 (09) :E632-E638

[5] Undetectable viral load and HIV transmission dynamics on an individual and population level: where next in the global HIV response? [J].

Bavinton, Benjamin R. ;

Rodger, Alison J. .

CURRENT OPINION IN INFECTIOUS DISEASES, 2020, 33 (01) :20-27

[6] Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study [J].

Bavinton, Benjamin R. ;

Pinto, Angie N. ;

Phanuphak, Nittaya ;

Grinsztejn, Beatriz ;

Prestage, Garrett P. ;

Zablotska-Manos, Iryna B. ;

Jin, Fengyi ;

Fairley, Christopher K. ;

Moore, Richard ;

Roth, Norman ;

Bloch, Mark ;

Pell, Catherine ;

McNulty, Anna M. ;

Baker, David ;

Hoy, Jennifer ;

Tee, Ban Kiem ;

Templeton, David J. ;

Cooper, David A. ;

Emery, Sean ;

Kelleher, Anthony ;

Grulich, Andrew E. .

LANCET HIV, 2018, 5 (08) :E438-E447

[7] The global response to HIV in men who have sex with men [J].

Beyrer, Chris ;

Baral, Stefan D. ;

Collins, Chris ;

Richardson, Eugene T. ;

Sullivan, Patrick S. ;

Sanchez, Jorge ;

Trapence, Gift ;

Katabira, Elly ;

Kazatchkine, Michel ;

Ryan, Owen ;

Wirtz, Andrea L. ;

Mayer, Kenneth H. .

LANCET, 2016, 388 (10040) :198-206

[8]

Cambiano V, 2018, LANCET INFECT DIS, V18, P85, DOI [10.1016/S1473-3099(17)30540-6, 10.1016/s1473-3099(17)30540-6]

[9]

Centers for Disease Control and Prevention (CDC), OR DAIL PREEXPOSURE

[10] Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial [J].

Choopanya, Kachit ;

Martin, Michael ;

Suntharasamai, Pravan ;

Sangkum, Udomsak ;

Mock, Philip A. ;

Leethochawalit, Manoj ;

Chiamwongpaet, Sithisat ;

Kitisin, Praphan ;

Natrujirote, Pitinan ;

Kittimunkong, Somyot ;

Chuachoowong, Rutt ;

Gvetadze, Roman J. ;

McNicholl, Janet M. ;

Paxton, Lynn A. ;

Curlin, Marcel E. ;

Hendrix, Craig W. ;

Vanichseni, Suphak .

LANCET, 2013, 381 (9883) :2083-2090

← 1 2 3 →